1 |
Li YJ, Li SL. Muscular characteristic of heparanase and its function in physiological and pathological process [J]. J Henan Univ:Med Sci, 2008, 27(3):14-19.
|
2 |
Baraz L, Haupt Y, Elkin M, et al. Tumor suppressor p53 regulates heparanase gene expression [J]. Oncogene, 2006, 25(28):3939-3947.
|
3 |
de Mestre AM, Rao S, Hornby JR, et al. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cell[J]. J Biol Chem, 2005, 280(42):35136-35147.
|
4 |
Elkin M, Cohen I, Zcharia E, et al. Regulation of heparanase gene expression by estrogen in breast cancer [J]. Cancer Res, 2003, 63(24):8821-8826.
|
5 |
Chen G, Wang D, Vikramadithyan R, et al. Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression[J]. Biochemistry, 2004, 43(17):4971-4977.
|
6 |
Hoogewerf AJ, Leone JW, Reardon IM, et al. CXC chemokines connective tissue activating peptide-Ⅲ and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes [J]. J Biol Chem, 1995, 270(7):3268-3277.
|
7 |
Dempsey LA, Plummer TB, Coombes SL, et al. Heparanase expression in invasive trophoblasts and acute vascular damage[J]. Glycobiology, 2000, 10(5):467-475.
|
8 |
Lerner I, Hermano E, Zcharia E, et al. Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice [J]. J Clin Invest, 2011, 121(5):1709-1721.
|
9 |
Zhang X, Wang B, Q'Callaghan P, et al. Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain [J]. Acta Neuropathol, 2012, 124(4):465-478.
|
10 |
Waterman M, Ben-Izhak O, Eliakim R, et al. Heparanase upregulation by colonic epithelium in inflammatory bowel disease [J]. Mod Pathol, 2007, 20(4):8-14.
|
11 |
Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis [J]. Nat Med, 2012, 18(8):1217-1223.
|
12 |
Carmeliet P. Angiogenesis in life, disease and medicine [J]. Nature, 2005, 438(7070):932-936.
|
13 |
Drake CJ. Embryonic and adult vasculogenesis[J]. Birth Defects Res C Embryo Today, 2003, 69(1):73-82.
|
14 |
Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J]. Nature, 1996, 380(6573):435-439.
|
15 |
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease[J]. Nat Med, 1995, 1(1):27-31.
|
16 |
Escobar Galvis ML, Jia J, Zhang X, et al. Transgenic or tumor-induced expression of heparanase upregulates sulfation of heparan sulfate[J]. Nat Chem Biol, 2007, 3(12):773-778.
|
17 |
Purushothaman A, Uyama T, Kobayashi F, et al. Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis [J]. Blood, 2010, 115(12):2449-2457.
|
18 |
Jiang G, Zheng L, Pu J, et al. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells[J]. PLoS One, 2012, 7(2):e31379.
|
19 |
Joyce JA, Freeman C, Meyer-Morse N, et al. A functional heparan sulfate mimetic implicates both heparanase and heparin sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer[J]. Oncogene, 2005, 24(25):4037-4051.
|
20 |
Yang Y, Macleod V, Miao HQ, et al. Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis[J]. J Biol Chem, 2007, 282(18):13326-13333.
|
21 |
Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis [J]. Int J Biochem Cell Biol, 2006, 38(12):2018-2039.
|
22 |
Johnstone KD, Karoli T, Liu L, et al. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth[J]. J Med Chem, 2010, 53(4):1686-1699.
|
23 |
Gaide Chevronnay HP, Selvais C, Emonard H, et al. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration[J]. Biochim Biophys Acta, 2012, 1824(1):146-156.
|
24 |
Kirn-Safran C, DSouza S, Carson D. Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation[J]. Semin Cell Dev Biol, 2008, 19(2):187-193.
|
25 |
Dempsey LA, Plummer TB, Coombes SL, et al. Heparanase expression in invasive trophoblasts and acute vascular damage[J]. Glycobiology, 2000, 10(5):467-475.
|
26 |
Kizaki K, Yamada O, Nakano H, et al. Cloning and localization of heparanase in bovine placenta[J]. Placenta, 2003, 24(4):424-430.
|
27 |
Xu X, Ding J, Rao G, et al. Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium[J]. Hum Reprod, 2007, 22(4):927-937.
|
28 |
Harris LK, Baker PN, Brenchley PE, et al. Trophoblast-derived heparanase is not required for invasion[J]. Placenta, 2008, 29(4):332-337.
|
29 |
Wirstlein PK, Mikolajczyk M, Skrzypczak J. Correlation of the expression of heparanase and heparin-binding EGF-like growth factor in the implantation window of nonconceptual cycle endometrium[J]. Folia Histochem Cytobiol, 2013, 51(2):127-134.
|
30 |
Revel A, Helman A, Koler M, et al. Heparanase improves mouse embryo implantation[J]. Fertil Steril, 2005, 83(3):580-586.
|
31 |
D'Souza SS, Daikoku T, Farach-Carson MC, et al. Heparanase expression and function during early pregnancy in mice[J]. Biol Reprod, 2007, 77(3):433-441.
|
32 |
Nadir Y, Henig I, Naroditzky I, et al. Involvement of heparanase in early pregnancy losses[J]. Thromb Res, 2010, 125(5):251-257.
|
33 |
Nadir Y, Brenner B. Heparanase procoagulant activity [J]. Thromb Res, 2012, 129(Suppl l):S76-79.
|
34 |
Teng YC, Lin QD, Lin JH, et al. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts[J]. J Perinat Med, 2009, 37(4):343-348.
|
35 |
Sela S, Natanson-Yaron S, Zcharia E, et al. Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase [J]. Circ Res, 2011, 108(9):1063-1070.
|
36 |
Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia[J]. N Engl J Med, 2004, 350(7):672-683.
|